Aceragen | 资产

Assets 更改 日
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
Clal Biotechnology ILS 182.69M 6.18M 2022-12
Compugen USD 67.61M 9.44M 2023-09
CSL USD 36.23B 786.4M 2023-06
Dynavax Technologies USD 997.1M 24.16M 2023-12
Eli Lilly USD 57.92B 3.1B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Grifols EUR 22.06B 631.75M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12



Aceragen 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.